Antioxidant and anti-inflammatory injectable hydrogel microspheres for in situ treatment of tendinopathy
Regenerative Biomaterials · 02.01.2024 · 11
DOI: 10.1093/rb/rbae007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 30.01.2024. Verfasst von Qibin Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical Univ…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program of Jiangsu science and technology Department, Jiangsu Graduate Student Cultivation Innovative Engineering Graduate Research and Practice Innovation Program, Program of Suzhou Health Commission.
Abstract (Originalsprache)
Tendinopathy is a common disorder that causes local dysfunction and reduces quality of life. Recent research has indicated that alterations in the inflammatory microenvironment play a vital role in the pathogenesis of tendinopathy. Herein, injectable methacrylate gelatin (GelMA) microspheres (GM) were fabricated and loaded with heparin-dopamine conjugate (HDC) and hepatocyte growth factor (HGF). GM@HDC@HGF were designed to balance the inflammatory microenvironment by inhibiting oxidative stress and inflammation, thereby regulating extracellular matrix (ECM) metabolism and halting tendon degeneration. Combining growth factors with heparin was expected to improve the encapsulation rate and maintain the long-term efficacy of HGF. In addition, the catechol groups on dopamine have adhesion and antioxidant properties, allowing potential attachment at the injured site, and better function synergized with HGF. GM@HDC@HGF injected in situ in rat Achilles tendinopathy (AT) models significantly down-regulated oxidative stress and inflammation, and ameliorated ECM degradation. In conclusion, the multifunctional platform developed presents a promising alternative for the treatment of tendinopathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215008, P.R. China.
- Department of Orthopedics, Kunshan Hospital of Traditional Chinese Medicine, Suzhou 215300, P.R. China.
- Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…
ORCID-Profile: Qibin Han
Förderung
- Program of Jiangsu science and technology Department
- Jiangsu Graduate Student Cultivation Innovative Engineering Graduate Research and Practice Innovation Program
- Program of Suzhou Health Commission
Zitieren
APA
Han, Q., Bai, L., Qian, Y., Zhang, X., Wang, J., Zhou, J., Cui, W., Hao, Y., & Yang, X. (2024). Antioxidant and anti-inflammatory injectable hydrogel microspheres for in situ treatment of tendinopathy. Regenerative Biomaterials, 11. https://doi.org/10.1093/rb/rbae007
Vancouver
Han Q, Bai L, Qian Y, Zhang X, Wang J, Zhou J, et al. Antioxidant and anti-inflammatory injectable hydrogel microspheres for in situ treatment of tendinopathy. Regenerative Biomaterials. 2024;11. doi:10.1093/rb/rbae007
BibTeX
@article{Han2024,
author = {Han, Qibin and Bai, Lang and Qian, Yinhua and Zhang, Xiaoyu and Wang, Juan and Zhou, Jing and Cui, Wenguo and Hao, Yuefeng and Yang, Xing},
title = {Antioxidant and anti-inflammatory injectable hydrogel microspheres for in situ treatment of tendinopathy},
journal = {Regenerative Biomaterials},
year = {2024},
volume = {11},
doi = {10.1093/rb/rbae007}
}
EUVIMED